RSS

tau aggregates

700 Alzheimer's patients have now been recruited for TauRx's latest phase of clinical trials. more

News

The posters will highlight recent cell and animal studies showing that a compound selected by Oligomerix's proprietary technology platform can reduce pathological tau aggregates. more